The Swell Study

HAE is a rare genetic condition that causes episodes of swelling in different parts of the body, including face, hands, feet, and airway. The study drug is a subcutaneous injection that is administered into the abdomen, upper arm, or thigh. Participants will receive a single dose.

Most current treatments are focused on reducing swelling. There are also preventative treatments, but these aren’t effective for all patients, and some need to be administered frequently. There is a need for more convenient and effective treatments to prevent these swelling episodes.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.